(Q48199350)

9 February 2018

title

Potential drug interactions and duplicate prescriptions among cancer patients. (English)

1 reference

9 February 2018

main subject

patient

0 references

author

Monika K Krzyzanowska

6

1 reference

9 February 2018

Ian F. Tannock

2

object named as

Ian F Tannock

1 reference

9 February 2018

author name string

Rachel P Riechelmann

1

1 reference

9 February 2018

Lisa Wang

3

1 reference

9 February 2018

Everardo D Saad

4

1 reference

9 February 2018

Nathan A Taback

5

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 April 2007

1 reference

9 February 2018

Journal of the National Cancer Institute

published in

1 reference

9 February 2018

volume

99

1 reference

9 February 2018

page(s)

592-600

1 reference

9 February 2018

issue

8

1 reference

9 February 2018

Drug interactions in oncology

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Bicalutamide: clinical pharmacokinetics and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome P450 3A4 substrate, in patients with chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Gefitinib, a novel, orally administered agent for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Drug-drug interactions among recently hospitalised patients--frequent but mostly clinically insignificant

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

The potential for drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Prospective evaluation of adverse drug interactions in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Fatal adverse drug events: the paradox of drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Identification of a gemcitabine-warfarin interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Interaction between paclitaxel and warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Aspirin-angiotensin-converting enzyme inhibitor coadministration and mortality in patients with heart failure: a dose-related adverse effect of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

The effect of intra-articular steroids on plasma salicylate concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

The influence of cimetidine on the pharmacokinetics of 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Combined use of SSRIs and NSAIDs increases the risk of gastrointestinal adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Tamoxifen-warfarin interaction: the Aberdeen hospitals drug file

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Effects of an acidic beverage (Coca-Cola) on absorption of ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Phenytoin and fluorouracil interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Potentiation of vitamin K antagonists by high-dose intravenous methylprednisolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Phenothiazine-induced phenytoin intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Moxifloxacin-warfarin interaction: a series of five case reports.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Paracetamol: a haemorrhagic risk factor in patients on warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

Alendronate and naproxen are synergistic for development of gastric ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK130

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJK130

1 reference

9 February 2018

PubMed ID

17440160

1 reference

9 February 2018